Professional
Added to YB: 2024-06-21
Pitch date: 2024-06-14
SILK [bullish]
Silk Road Medical, Inc
+29.18%
current return
Author Info
No bio for this author
Company Info
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR).
Market Cap
$1.1B
Pitch Price
$21.28
Price Target
32.00 (+16%)
Dividend
N/A
EV/EBITDA
-17.89
P/E
-19.06
EV/Sales
5.38
Sector
Health Care Equipment and Supplies
Category
growth
Silk Road Medical, Inc: Raising target to $32 from $24
SILK: Raised PT to $32 on path to '24 profitability via new products (NPS PLUS, tapered stent), larger sales force. $2.3B intl market opp for TCAR procedure treating CAD. Q1 revs +21%, gross margin 75% (+600bps). Risks: small-cap volatility, supply chain, reimbursement.
Read full article (5 min)